ICD-10 Coding for Chemotherapy-Induced Peripheral Neuropathy(G62.0, T45.1x5A)
Complete ICD-10-CM coding and documentation guide for Chemotherapy-Induced Peripheral Neuropathy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Chemotherapy-Induced Peripheral Neuropathy
G60-G64Primary Range
Polyneuropathies and other disorders of the peripheral nervous system
This range includes codes for various types of neuropathies, including drug-induced neuropathy.
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
This range includes codes for adverse effects of drugs, including chemotherapy agents.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G62.0 | Drug-induced polyneuropathy | Use when neuropathy is directly attributed to chemotherapy agents. |
|
| T45.1x5A | Adverse effect of antineoplastic and immunosuppressive drugs | Use as a secondary code to specify the adverse effect of chemotherapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for chemotherapy-induced peripheral neuropathy
Essential facts and insights about Chemotherapy-Induced Peripheral Neuropathy
Primary ICD-10-CM Codes for chemotherapy induced peripheral neuropathy
Decision Criteria
clinical Criteria
- Neuropathy onset after chemotherapy initiation
documentation Criteria
- Document specific chemotherapy agent and temporal relationship
Applicable To
- Neuropathy due to chemotherapy
Excludes
- Hereditary neuropathy (G60.9)
Clinical Validation Requirements
- Nerve conduction studies showing reduced sensory amplitude
- Temporal relationship with chemotherapy initiation
Code-Specific Risks
- Misclassification with hereditary neuropathy codes
Coding Notes
- Ensure documentation specifies the chemotherapy agent responsible for neuropathy.
T45.1x5A - Adverse effect of antineoplastic and immunosuppressive drugs
Use as a secondary code to specify the adverse effect of chemotherapy.
Applicable To
- Adverse effects of chemotherapy drugs
Clinical Validation Requirements
- Documentation of chemotherapy regimen
- Adverse effect noted during treatment
Coding Notes
Ensure correct 7th character is applied based on treatment phase.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Paresthesia of skin
R20.1Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Chemotherapy-Induced Peripheral Neuropathy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G62.0.
Impact
Clinical: Inaccurate treatment records., Regulatory: Non-compliance with documentation standards., Financial: Potential reimbursement issues.
Mitigation Strategy
Use templates that prompt for agent specification., Regular training on documentation standards.
Impact
Reimbursement: May lead to incorrect reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate healthcare data reporting.
Mitigation Strategy
Ensure documentation specifies drug-induced neuropathy.
Impact
Reimbursement: Affects risk adjustment and reimbursement accuracy., Compliance: Non-compliance with ICD-10 coding rules., Data Quality: Leads to data inaccuracies in treatment tracking.
Mitigation Strategy
Apply the correct 7th character based on treatment phase.
Impact
Inadequate documentation of chemotherapy-induced neuropathy.
Mitigation Strategy
Implement comprehensive documentation templates.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Chemotherapy-Induced Peripheral Neuropathy, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Chemotherapy-Induced Peripheral Neuropathy
Use these documentation templates to ensure complete and accurate documentation for Chemotherapy-Induced Peripheral Neuropathy. These templates include all required elements for proper coding and billing.
Oncology Progress Note
Specialty: OncologyRequired Elements
- Subjective: Patient's description of symptoms
- Objective: Physical examination findings
- Assessment: Diagnosis and causative agent
- Plan: Treatment adjustments and referrals
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Chemotherapy-Induced Peripheral Neuropathy? Ask your questions below.